Mendelian Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 21
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.06M
Latest Deal Amount
  • Investors
  • 4

Mendelian General Information

Description

Provider of a genetic compatibility platform intended to treat rare diseases. The company uses machine learning and knowledge reasoning-led diagnosis to detect rare diseases conditions, enabling doctors to help patients earlier by finding the undiagnosed.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Business/Productivity Software
Primary Office
  • 239 Old Street
  • London EC1V 9EY
  • England, United Kingdom

Mendelian Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mendelian Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 09-Apr-2021 $1.06M 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 20-Feb-2020 00000 00000 00.00 Completed Generating Revenue
4. Accelerator/Incubator 01-Oct-2019 00000 Completed Generating Revenue
3. Grant 04-Feb-2019 00000 00000 Completed Startup
2. Angel (individual) 30-Jun-2018 $200K $200K 00.000 Completed Startup
1. Accelerator/Incubator 17-Feb-2015 Completed Startup
To view Mendelian’s complete valuation and funding history, request access »

Mendelian Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000 000 00 000 0.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 45,405 $0.001384 $5.08 $5.08 1x $5.08 3.48%
Ordinary 70,876 $0.001384 $2.93 $2.93 1x $2.93 5.44%
To view Mendelian’s complete cap table history, request access »

Mendelian Executive Team (4)

Name Title Board Seat Contact Info
Rudy Benfredj Co-Founder & Chief Executive Officer
Francisco Tosina Investigator of Research Project
You’re viewing 2 of 4 executive team members. Get the full list »

Mendelian Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mendelian Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crista Galli Ventures Venture Capital Minority 000 0000 000000 0
Oxford Academic Health Science Network Accelerator/Incubator Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Imperial Create Lab Accelerator/Incubator 000 0000 000000 0
To view Mendelian’s complete investors history, request access »